Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/16469753

Download in:

View as

General Info

PMID
16469753